$梯瓦制药(TEVA_老虎社区_美港股上老虎

跟我重名算你厉害
2017-01-31

$梯瓦制药(TEVA)$ 有朋友知道今天盘后暴跌是因为什么吗？

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

大黑豹
·2017-01-31
因裁决让最畅销的多发性硬化症药物Copaxone四项专利无效，这次判决可能导致公司近20%的市场被仿制药占领。
回复
1
举报
跟我重名算你厉害
·2017-02-02
@大黑豹谢谢了
回复
点赞
举报

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":42990,"tweetId":"42990","gmtCreate":1485820266323,"gmtModify":1704874874192,"author":{"id":95665808197246,"idStr":"95665808197246","authorId":95665808197246,"authorIdStr":"95665808197246","name":"跟我重名算你厉害","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>$梯瓦制药(TEVA)$ 有朋友知道今天盘后暴跌是因为什么吗？</p></body></html>","htmlText":"<html><head></head><body><p>$梯瓦制药(TEVA)$ 有朋友知道今天盘后暴跌是因为什么吗？</p></body></html>","text":"$梯瓦制药(TEVA)$ 有朋友知道今天盘后暴跌是因为什么吗？","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/42990","repostId":0,"isVote":1,"tweetType":1,"viewCount":2226,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["TEVA"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":51,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":228430,"commentId":"228430","gmtCreate":1485828398740,"gmtModify":1485828398740,"authorId":3444476247883935,"author":{"id":3444476247883935,"idStr":"3444476247883935","authorId":3444476247883935,"name":"大黑豹","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":42990,"objectIdStr":"42990","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"因裁决让最畅销的多发性硬化症药物Copaxone四项专利无效，这次判决可能导致公司近20%的市场被仿制药占领。","text":"因裁决让最畅销的多发性硬化症药物Copaxone四项专利无效，这次判决可能导致公司近20%的市场被仿制药占领。","html":"因裁决让最畅销的多发性硬化症药物Copaxone四项专利无效，这次判决可能导致公司近20%的市场被仿制药占领。","likeSize":1,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":229297,"commentId":"229297","gmtCreate":1485994601734,"gmtModify":1485994601734,"authorId":95665808197246,"author":{"id":95665808197246,"idStr":"95665808197246","authorId":95665808197246,"name":"跟我重名算你厉害","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":42990,"objectIdStr":"42990","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"@大黑豹 谢谢了","text":"@大黑豹 谢谢了","html":"@大黑豹 谢谢了","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"hasMoreComment":true,"orderType":2}

评论（2）

热议股票